Reversible lineage-specific priming of human embryonic stem cells can be exploited to optimize the yield of differentiated cells

Stem Cells

Volumn 33, Issue 4, 2015, Pages 1142-1152

  Lee, Jung Bok ^a   Graham, Monica ^a   Collins, Tony J ^a   Lee, Jong Hee ^a   Hong, Seok Ho ^a   McNicol, Amie Jamie ^a   Shapovalova, Zoya ^a   Bhatia, Mickie ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Developmental biology; Differentiation; Embryonic stem cells; Pluripotent stem cells; Self renewal

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GLIA CELL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MOUSE; NERVE CELL; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; STEM CELL EXPANSION; ANIMAL; CELL CULTURE TECHNIQUE; CELL LINEAGE; CELL PROLIFERATION; HUMAN EMBRYONIC STEM CELL; MALE; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; PROCEDURES; SCID MOUSE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; HUMAN EMBRYONIC STEM CELLS; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID;

EID: 84925625542     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1952     Document Type: Article

References (35)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
2. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920.
3. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
4. Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451: 141-146.
5. Schwartz SD, Hubschman JP, Heilwell G, et al. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012; 379: 713-720.
6. Skottman H, Dilber MS, Hovatta O,. The derivation of clinical-grade human embryonic stem cell lines. FEBS Lett 2006; 580: 2875-2878.
7. Crook JM, Peura TT, Kravets L, et al. The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 2007; 1: 490-494.
8. Richards M, Fong CY, Chan WK, et al. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 2002; 20: 933-936.
9. Xu C, Inokuma MS, Denham J, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001; 19: 971-974.
10. Lee JB, Lee JE, Park JH, et al. Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol Reprod 2005; 72: 42-49.
11. Li Y, Powell S, Brunette E, et al. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng 2005; 91: 688-698.
12. Ellerstrom C, Strehl R, Moya K, et al. Derivation of a xeno-free human embryonic stem cell line. Stem Cells 2006; 24: 2170-2176.
13. Chin AC, Padmanabhan J, Oh SK, et al. Defined and serum-free media support undifferentiated human embryonic stem cell growth. Stem Cells Dev 2010; 19: 753-761.
14. Hannoun Z, Fletcher J, Greenhough S, et al. The comparison between conditioned media and serum-free media in human embryonic stem cell culture and differentiation. Cell Reprogram 2010; 12: 133-140.
15. Singh H, Mok P, Balakrishnan T, et al. Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res 2010; 4: 165-179.
16. Ludwig TE, Levenstein ME, Jones JM, et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 2006; 24: 185-187.
17. Rajala K, Hakala H, Panula S, et al. Testing of nine different xeno-free culture media for human embryonic stem cell cultures. Hum Reprod 2007; 22: 1231-1238.
18. Chen G, Gulbranson DR, Hou Z, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011; 8: 424-429.
19. Werbowetski-Ogilvie TE, Bosse M, Stewart M, et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol 2009; 27: 91-97.
20. Hong SH, Rampalli S, Lee JB, et al. Cell fate potential of human pluripotent stem cells is encoded by histone modifications. Cell Stem Cell 2011; 9: 24-36.
21. Chadwick K, Wang L, Li L, et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003; 102: 906-915.
22. Wang L, Li L, Shojaei F, et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 2004; 21: 31-41.
23. Cerdan C, McIntyre BA, Mechael R, et al. Activin a promotes hematopoietic fated mesoderm development through upregulation of brachyury in human embryonic stem cells. Stem Cells Dev 2012; 21: 2866-2877.
24. Wang L, Li L, Menendez P, et al. Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood 2005; 105: 4598-4603.
25. Wang L, Menendez P, Cerdan C, et al. Hematopoietic development from human embryonic stem cell lines. Exp Hematol 2005; 33: 987-996.
26. Wang L, Cerdan C, Menendez P, et al. Derivation and characterization of hematopoietic cells from human embryonic stem cells. Methods Mol Biol 2006; 331: 179-200.
27. Ludwig TE, Bergendahl V, Levenstein ME, et al. Feeder-independent culture of human embryonic stem cells. Nat Methods 2006; 3: 637-646.
28. Lee JH, Schütte D, Wulf G, et al. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet 2006; 15: 201-211.
29. Lee JH, Jung C, Javadian-Elyaderani P, et al. Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein Piwil2. Cancer Res 2010; 70: 4569-4579.
30. Bock C, Kiskinis E, Verstappen G, et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011; 144: 439-452.
31. Nagaoka M, Si-Tayeb K, Akaike T, et al. Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum. BMC Dev Biol 2010; 10: 60.
32. Ojala M, Rajala K, Pekkanen-Mattila M, et al. Culture conditions affect cardiac differentiation potential of human pluripotent stem cells. PLoS One 2012; 7: e48659.
33. Bendall SC, Stewart MH, Menendez P, et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 2007; 448: 1015-1021.
34. Stewart MH, Bendall SC, Bhatia M,. Deconstructing human embryonic stem cell cultures: Niche regulation of self-renewal and pluripotency. J Mol Med 2008; 86: 875-886.
35. Kohler EE, Cowan CE, Chatterjee I, et al. NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis. Blood 2011; 117: 1761-1769.